JP Morgan Chase & Co. vs MetLife, Inc. — Stock Comparison

JP Morgan Chase & Co. (JPM) and MetLife, Inc. (MET) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

Q·Score Winner
JP Morgan Chase & Co.
JPM7.4/10vs 6.4/10

JP Morgan Chase & Co. scores ahead of MetLife, Inc. on Q·Score (7.4 vs 6.4 out of 10), led by Quality (9 vs 6.6) and Growth (9 vs 7.4). MetLife, Inc. scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for JPM (+7.1%) than for MET (+5.0%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
JPMMET

Q·Score Breakdown

7.4
Bullish
Overall
6.4
Neutral
9
Quality
6.6
5.5
Health
5.5
9
Growth
7.4
6.5
Valuation
5.9
6.2
Sentiment
6.8
JPM

High-quality business with 16% return on equity and 34% profit margins.

MET

Earnings growing 36% year-over-year.

Analyst Consensus

Neutral
+7.1%
Target $342.19
21 analysts
Bullish
+5.0%
Target $92.00
16 analysts

Fundamentals

JPM
MET
15.3×
Trailing P/E
17.0×
13.6×
Forward P/E
8.0×
33.94%
Profit Margin
4.67%
0.00%
Gross Margin
23.75%
16.47%
ROE
13.01%
12.70%
Revenue Growth
2.70%
17.20%
Earnings Growth
35.90%
1.00
Beta
0.78
1.88%
Dividend Yield
2.70%
$855.8B
Market Cap
$56.4B
52-Week Range
JPM
$26874% of range$337
MET
$6791% of range$90

Frequently Asked Questions

JPM vs MET: which stock scores better overall?

Based on Q·Score, JP Morgan Chase & Co. (JPM) scores 7.4/10 versus MetLife, Inc. (MET) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: JPM or MET?

JP Morgan Chase & Co. (JPM) scores higher on Growth (9/10 vs 7.4/10). JP Morgan Chase & Co. reports revenue growth (12.7% YoY) while MetLife, Inc. reports (2.7% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is JPM or MET more attractively valued?

JP Morgan Chase & Co. (JPM) scores higher on Valuation (6.5/10 vs 5.9/10). JPM trades at 13.6× P/E versus MET at 8.0×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about JPM vs MET?

There are 21 analysts covering JPM with a consensus price target of $342.19, and 16 analysts covering MET with a consensus target of $92.00. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: JPM or MET?

JP Morgan Chase & Co. (JPM) scores higher on Quality (9/10 vs 6.6/10). Net profit margin: JPM at 33.9%, MET at 4.7%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: JPM or MET?

JP Morgan Chase & Co. (JPM) scores higher on Financial Health (5.5/10 vs 5.5/10). Market beta: JPM at 1.00, MET at 0.78. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of JPM and MET?

JP Morgan Chase & Co. (JPM) has a market capitalisation of $855.8B, while MetLife, Inc. (MET) has a market cap of $56.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do JPM or MET pay dividends?

JPM pays a dividend yield of 1.88%, while MET pays a dividend yield of 2.70%. Dividend yields fluctuate with share price and company payout decisions.

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026